HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “Company”), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced the pricing of a public offering of 28,000,000 shares of common stock (or pre-funded warrants in lieu thereof), together with common warrants to purchase up to 28,000,000 shares of common stock at a combined public offering price of $0.25 per share (or pre-funded warrant in lieu thereof) and associated common warrant. The common warrants will have an exercise price of $0.25 per share, are exercisable upon issuance and will expire five years thereafter. …

The YieldMax MSTR Option Income Strategy ETF (NYSEARCA:MSTY) has captured significant attention among investors seeking high-yield income through its synthetic covered call strategy tied to Strategy (NASDAQ:MSTR) stock.

ASML dominates advanced lithography with its exclusive EUV systems. Strong financials, high ROIC, and a unique competitive edge suggest the stock is undervalued by ~13%. Thanks to its leadership in EUV technology and continuous R&D investments, ASML is expected to maintain high margins and strong cash flows. ASML's exposure to key semiconductor markets and limited customer diversification pose risks, but its technological moat and robust fundamentals justify a moderate upside potential.

Kraft Heinz Co (NASDAQ:KHC, ETR:KHNZ) said on Tuesday it will eliminate artificial food dyes from all US products by the end of 2027, becoming one of the first major packaged food companies to commit to a full phaseout of synthetic coloring amid growing scrutiny from consumers and US regulators. The decision comes as the US Department of Health and Human Services, under Secretary Robert F Kennedy Jr, ramps up pressure on the food industry to remove petroleum-based synthetic dyes, which have been linked to potential health risks.

JetBlue Airways is reducing flights, evaluating routes and cutting budgets amid weak consumer demand, CEO Joanna Geraghty told staff in an internal note.

Palo Alto Networks' SASE ARR surges 36% as Prisma Access Browser drives seat growth and builds a strong nine-figure sales pipeline.

Optum drives growth for UNH as rising Medicare Advantage costs pressure its health benefits unit.

NMI Holdings is well-positioned for growth, with higher new insurance written volume, a comprehensive reinsurance program and prudent capital deployment.

CBSH agrees to acquire FineMark for $585 million in stock, boosting earnings and expanding wealth presence in key markets.

UAA's Q4 margin hits 46.7%, banking on lower supply costs and fewer DTC markdowns despite regional mix headwinds.

ZS lands major enterprise deals as the adoption of GenAI and SaaS fuels demand for its expanding data security platform.

The big banks will really kick the Q2 earnings cycle into a higher gear in a few weeks, but the reality is that earnings season is never ‘over'. We've heard from several companies over recent weeks, whose results we'll include as part of the broader Q2 tally.

Banking giant Barclays has reiterated its bullish stance on semiconductor titan Nvidia (NASDAQ: NVDA), raising its price target to $200, driven by surging demand for its artificial intelligence (AI) products.

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 12, 2025.

Intel Corporation is painfully losing market share to Advanced Micro Devices, with the latter looking to take 40% share this year. We think Intel's share loss to AMD is temporary and should reverse next year with 18A and new product line up more so after Nova Lake spec leaks. Management is laser-focused on restoring gross margins above 50% and is aggressively cutting costs through layoffs and potential divestitures.

Podcasts Renewed Are Cold Case Files, I Survived, American Justice, City Confidential and Ancient Aliens Total Combined Downloads Across All Five Podcasts Tops 160 Million LOS ANGELES, June 17, 2025 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ: PODC ), a leading publisher and podcast sales network, announced today that it has extended its agreement with A+E Networks for the exclusive sales and distribution rights to five popular true crime podcasts; Cold Case Files, I Survived, American Justice, City Confidential and Ancient Aliens. Through PodcastOne's PodcastOne Pro division, the company is able to transform podcast ideas into thriving on-air productions.

Sage Therapeutics (SAGE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

U.S. equities declined at midday as investors continued to digest the fighting in the Middle East. The Nasdaq, Dow Jones Industrial Average, and S&P 500 all edged lower.

Francisco Gomes Neto, CEO of Embraer, the world's third largest aircraft maker discusses global demand for commercial and executive aviation.

NewtekOne's bad decision to abandon the BDC model has really come to bite. Earnings are now lower than in 2021 despite far higher leverage. We bought despite the challenges and tell you why.